ASCO 2022 Conference Coverage


 

ASCO 2022 on a Phase II Study of Hyper-CVAD With Sequential Blina +/- Inotuzumab Ozogamicin in Adults With Newly Diagnosed B-Cell ALL

25 views
June 15, 2022
Comments 0
Login to view comments. Click here to Login